[1]
M. R. Godoy, S. Boscato, e I. Heineck, “Cost Minimization Analysis (CMA) of XELOX versus MFOLFOX6 in the treatment of colorectal cancer in a public hospital in Brazil”, JAFF, vol. 3, nº s.1, jan. 2023.